Cenova Capital Leads Series A Round In Chinese AI Medical Firm Phoebus

Login to View

Phoebus Medical Technology, an artificial intelligence-based chronic disease management company, has raised tens of millions of RMB in series A round of financing from healthcare and life sciences-focused Cenova Capital, according to Chinese media reports.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Read 3 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription for $359

Enjoy comprehensive and exclusive data you can't find elsewhere!

Subscribe for $359


Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in

China Money Network Subscription

RELATED NEWS